A Racial Disparity in Schizophrenia Diagnoses in Nursing Homes
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
F.D.A. Panel Recommends Moderna Booster for Certain Groups
Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boost
F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individuals
A Food and Drug Administration advisory panel recommended a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs.
F.D.A. Vaccine Booster Panel: Here’s Who Is on the Roster
The experts’ recommendations, though not binding, are likely to influence what the Food and Drug Administration decides on whether to authorize the boosters.
Where Things Stand on Boosters for Three Vaccines in the U.S.
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard may help.
Coronavirus Briefing: What Happened Today
Moderna sells its vaccine almost exclusively to wealthy countries.
Merck Asks F.D.A. for Emergency Approval of Covid Pill
The company is seeking authorization for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be eligible.
Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.
Coronavirus Briefing: What Happened Today
Vaccines for kids inch forward.
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11
The agency has promised to move quickly on the request and has tentatively scheduled a meeting at the end of the month to consider it.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.